CC
CELG

Curian Capital’s Celgene Corp CELG Stock Holding History

Curian Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,833
Closed -$2.38M – 470
2015
Q4 		$2.38M Sell
19,833
-36,892
-65% -$4.27M 0.18% 132
2015
Q3 		$6.14M Sell
56,725
-25,848
-31% -$3.21M 0.16% 156
2015
Q2 		$9.56M Sell
82,573
-14,213
-15% -$1.62M 0.16% 154
2015
Q1 		$11.2M Sell
96,786
-2,114
-2% -$253K 0.19% 134
2014
Q4 		$11.1M Sell
98,900
-6,537
-6% -$689K 0.19% 130
2014
Q3 		$9.99M Sell
105,437
-1,829
-2% -$165K 0.18% 136
2014
Q2 		$9.21M Buy
107,266
+2,706
+3% +$206K 0.16% 152
2014
Q1 		$7.3M Sell
104,560
-96,180
-48% -$7.62M 0.13% 184
2013
Q4 		$17M Sell
200,740
-31,588
-14% -$2.5M 0.3% 65
2013
Q3 		$17.9M Sell
232,328
-2,922
-1% -$205K 0.32% 49
2013
Q2 		$13.8M Buy
+235,250
New +$14.2M 0.25% 66

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Curian Capital's CELG Position: Q1 2016 in Review

Curian Capital sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 19,833 shares — an estimated $2.38M sold.

Curian Capital first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $17.9M in Q3 2013. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Curian Capital reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 19,833 Celgene Corp shares in Q1 2016, an estimated $2.38M.
  • Curian Capital first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Celgene Corp position peaked at $17.9M in Q3 2013.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.